Psoriatic Arthritis

Lisa Sammaritano, MD: Rheumatic Diseases, Pregnancy, and the Importance of Communication

September 14, 2020

Rheumatologists and OB-GYNs must communicate openly with each other and to patients with rheumatic diseases who are considering pregnancy.

PASDAS Sensitive at Detecting Changes in Psoriatic Disease Activity

September 14, 2020

Which composite measures detect the highest level of changes in psoriatic disease activity.

Ashley Crew, MD: Clinical Manifestations in Rheum Care Requiring Derm Consult

September 12, 2020

When a rheum patient might need to consult with a dermatologist.

Filgotinib Effective, Safe for Psoriatic Arthritis

September 11, 2020

Filgotinib was well-tolerated and sustained efficacy in a 52-week extension study.

Ustekinumab Safe and Efficacious in Young and Elderly Patients with Psoriatic Arthritis

September 10, 2020

According to a poster presented at CCR East 2020, patients

Upadacitinib Demonstrates Safety and Efficacy for Atopic Dermatitis

July 21, 2020

Upadacitinib 15 mg and 30 mg outperformed placebo in Measure Up 2, the second part of a phase 3 study on the monotherapy.

FDA Approves Guselkumab for Active Psoriatic Arthritis

July 14, 2020

Guselkumab represents the first FDA approved medication for active psoriatic arthritis that selectively inhibits interleukin-23.

ACR Supports Use of Telemedicine for Rheumatology

July 01, 2020

The statement contains positions and oppositions for telemedicine, along with highlights barriers and opportunities for patients and rheumatology professionals.

Vibeke Strand, MD: Important Rheumatology Data Coming Out of EULAR

June 11, 2020

Dr. Vibeke Strand discusses the relationship between COVID-19 and psoriatic arthritis.

Vibeke Strand, MD: Comorbidities Make Treating Psoriatic Arthritis Difficult

June 11, 2020

Dr. Vibeke Strand discusses how better treatment of psoriatic arthritis could yield better treatments for NASH.